SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001461993-19-000044
Filing Date
2019-08-09
Accepted
2019-08-09 07:37:27
Documents
3
Period of Report
2019-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q22019earnings8-k.htm 8-K 31764
2 EXHIBIT 99.1 ex991q22019earningsrelease.htm EX-99.1 487215
3 EXHIBIT 99.2 ex992release.htm EX-99.2 19921
  Complete submission text file 0001461993-19-000044.txt   540347
Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35405 | Film No.: 191011318
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences